BioCryst Pharmaceuticals, Inc. (BCRX)
7.61
-0.07
(-0.91%)
USD |
NASDAQ |
Nov 13, 16:00
7.60
-0.01
(-0.13%)
After-Hours: 19:59
BioCryst Pharmaceuticals Price : 7.61 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 7.67 | 7.75 | 7.49 | 7.61 | 2.316M |
| Nov 12, 2026 | 7.58 | 7.78 | 7.46 | 7.68 | 3.572M |
| Nov 11, 2026 | 7.56 | 7.70 | 7.500 | 7.65 | 2.642M |
| Nov 10, 2026 | 7.57 | 7.70 | 7.455 | 7.53 | 4.047M |
| Nov 09, 2026 | 7.76 | 7.775 | 7.54 | 7.63 | 5.517M |
| Nov 06, 2026 | 7.81 | 7.83 | 7.38 | 7.69 | 5.211M |
| Nov 05, 2026 | 8.275 | 8.275 | 7.415 | 7.63 | 15.36M |
| Nov 04, 2026 | 8.425 | 8.86 | 8.105 | 8.24 | 10.23M |
| Nov 03, 2026 | 8.23 | 8.62 | 8.189 | 8.57 | 6.533M |
| Nov 02, 2026 | 8.49 | 8.52 | 8.22 | 8.245 | 4.090M |
| Oct 30, 2026 | 8.55 | 8.617 | 8.38 | 8.47 | 3.527M |
| Oct 29, 2026 | 8.45 | 8.56 | 8.39 | 8.52 | 4.519M |
| Oct 28, 2026 | 8.05 | 8.445 | 8.005 | 8.37 | 3.937M |
| Oct 27, 2026 | 7.925 | 8.12 | 7.81 | 8.10 | 8.753M |
| Oct 26, 2026 | 7.69 | 8.00 | 7.66 | 7.88 | 4.381M |
| Oct 23, 2026 | 7.71 | 7.764 | 7.52 | 7.65 | 2.746M |
| Oct 22, 2026 | 7.78 | 7.88 | 7.66 | 7.78 | 4.806M |
| Oct 21, 2026 | 8.04 | 8.05 | 7.73 | 7.75 | 5.034M |
| Oct 20, 2026 | 8.11 | 8.13 | 7.84 | 7.94 | 8.455M |
| Oct 19, 2026 | 7.77 | 8.09 | 7.77 | 8.07 | 9.774M |
| Oct 16, 2026 | 7.96 | 8.015 | 7.74 | 7.79 | 4.431M |
| Oct 15, 2026 | 8.105 | 8.24 | 7.945 | 8.02 | 4.504M |
| Oct 14, 2026 | 8.02 | 8.18 | 7.97 | 8.05 | 5.650M |
| Oct 13, 2026 | 8.22 | 8.315 | 8.06 | 8.07 | 3.043M |
| Oct 12, 2026 | 8.49 | 8.55 | 8.24 | 8.36 | 3.467M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 100.27 |
| Neurocrine Biosciences, Inc. | 167.40 |
| Agenus, Inc. | 6.73 |
| Amgen, Inc. | 465.67 |
| Anika Therapeutics, Inc. | 13.40 |
Price Related Metrics
| PS Ratio | 1.967 |
| PEG Ratio | -0.0018 |
| Price to Free Cash Flow | 5.422 |
| Earnings Yield | -18.67% |
| Market Cap | 1.949B |
| PEGY Ratio | -0.0018 |
| Operating PE Ratio | 4.632 |
| Normalized PE Ratio | 12.03 |